BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15850442)

  • 1. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
    Glaser A; Arakaki D; Chan GM; Hoffman RS
    Med J Aust; 2005 Apr; 182(8):427; author reply 427, 429. PubMed ID: 15850442
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal naloxone administration for treatment of opioid overdose.
    Robinson A; Wermeling DP
    Am J Health Syst Pharm; 2014 Dec; 71(24):2129-35. PubMed ID: 25465584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best evidence topic report. Intranasal naloxone in suspected opioid overdose.
    Ashton H; Hassan Z
    Emerg Med J; 2006 Mar; 23(3):221-3. PubMed ID: 16498165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
    Kelly AM; Kerr D; Dietze P; Patrick I; Walker T; Koutsogiannis Z
    Med J Aust; 2005 Jan; 182(1):24-7. PubMed ID: 15651944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.
    Doe-Simkins M; Walley AY; Epstein A; Moyer P
    Am J Public Health; 2009 May; 99(5):788-91. PubMed ID: 19363214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal naloxone for life threatening opioid toxicity.
    Kelly AM; Koutsogiannis Z
    Emerg Med J; 2002 Jul; 19(4):375. PubMed ID: 12101174
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence-Based Guidelines for EMS Administration of Naloxone.
    Williams K; Lang ES; Panchal AR; Gasper JJ; Taillac P; Gouda J; Lyng JW; Goodloe JM; Hedges M
    Prehosp Emerg Care; 2019; 23(6):749-763. PubMed ID: 30924736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.
    Jeffery RM; Dickinson L; Ng ND; DeGeorge LM; Nable JV
    J Am Coll Health; 2017 Apr; 65(3):212-216. PubMed ID: 28059635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increase in per-patient naloxone requirements in an opioid epidemic.
    Birmingham LE; Nielson JA
    Am J Emerg Med; 2017 Dec; 35(12):1958-1959. PubMed ID: 28633907
    [No Abstract]   [Full Text] [Related]  

  • 10. Does intranasal naloxone administration increase the risk of 2019 coronavirus disease transmission?
    Leong YC; Verbeek PR
    CJEM; 2020 Nov; 22(6):e20. PubMed ID: 32393409
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Diagnosis of drug overdose by rapid reversal with naloxone.
    Barrie J; May G
    Emerg Med J; 2006 Nov; 23(11):874-5. PubMed ID: 17057146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial.
    Dietze P; Jauncey M; Salmon A; Mohebbi M; Latimer J; van Beek I; McGrath C; Kerr D
    JAMA Netw Open; 2019 Nov; 2(11):e1914977. PubMed ID: 31722024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone Administration for Opioid Overdose Reversal in the Prehospital Setting: Implications for Pharmacists.
    Weaver L; Palombi L; Bastianelli KMS
    J Pharm Pract; 2018 Feb; 31(1):91-98. PubMed ID: 28399697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic.
    Klebacher R; Harris MI; Ariyaprakai N; Tagore A; Robbins V; Dudley LS; Bauter R; Koneru S; Hill RD; Wasserman E; Shanes A; Merlin MA
    Prehosp Emerg Care; 2017; 21(6):682-687. PubMed ID: 28686547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Suspected Opioid Overdose With Naloxone in Out-of-Hospital Settings: A Systematic Review.
    Chou R; Korthuis PT; McCarty D; Coffin PO; Griffin JC; Davis-O'Reilly C; Grusing S; Daya M
    Ann Intern Med; 2017 Dec; 167(12):867-875. PubMed ID: 29181532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of naloxone by paramedics.
    Barton ED; Ramos J; Colwell C; Benson J; Baily J; Dunn W
    Prehosp Emerg Care; 2002; 6(1):54-8. PubMed ID: 11789651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another piece of the puzzle.
    Meador SA
    Acad Emerg Med; 1996 Jul; 3(7):657. PubMed ID: 8816179
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.
    Barton ED; Colwell CB; Wolfe T; Fosnocht D; Gravitz C; Bryan T; Dunn W; Benson J; Bailey J
    J Emerg Med; 2005 Oct; 29(3):265-71. PubMed ID: 16183444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose.
    Robertson TM; Hendey GW; Stroh G; Shalit M
    Prehosp Emerg Care; 2009; 13(4):512-5. PubMed ID: 19731165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.